STOCK TITAN

NEA entities report 6.3% Celcuity (CELC) stake in Schedule 13D/A update

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Growth Equity Opportunities 18 VGE, LLC and related New Enterprise Associates funds and managers filed Amendment No. 3 to their Schedule 13D for Celcuity Inc. common stock. They report beneficial ownership of 2,910,561 shares, representing 6.3% of Celcuity’s common stock, based on 46,271,259 shares outstanding as of November 6, 2025 as reported in the company’s Form 10-Q. The filing explains that GEO holds the shares of record and that the NEA entities and individual managers may be deemed beneficial owners through their control roles, while each disclaims beneficial ownership beyond shares held of record.

On January 14, 2026, GEO distributed 625,000 shares to NEA 18 VGE, which then distributed them pro rata to its partners for no consideration, and NEA Partners 18 VGE briefly held and redistributed 9,375 shares. A portion of these were indirectly received by entities associated with certain managers and sold on January 15, 2026 as detailed in Schedule A. The filing also notes that on October 6, 2025, GEO exercised 139,130 warrants for 1,391,300 preferred warrant shares, which were immediately converted into common stock, and that GEO no longer holds any warrants or preferred warrant shares.

Positive

  • None.

Negative

  • None.





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Growth Equity Opportunities 18 VGE, LLC
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer
Date:01/16/2026
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:01/16/2026
NEA 18 Venture Growth Equity, L.P.
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer
Date:01/16/2026
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:01/16/2026
NEA Partners 18 VGE, L.P.
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer
Date:01/16/2026
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:01/16/2026
NEA 18 VGE GP, LLC
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer
Date:01/16/2026
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:01/16/2026
Ali Behbahani
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Ali Behbahani
Date:01/16/2026
Carmen Chang
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Carmen Chang
Date:01/16/2026
Anthony A. Florence, Jr.
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Anthony A. Florence, Jr.
Date:01/16/2026
Mohamad H. Makhzoumi
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Mohamad H. Makhzoumi
Date:01/16/2026
Edward T. Mathers
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Edward T. Mathers
Date:01/16/2026
Scott D. Sandell
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Scott D. Sandell
Date:01/16/2026
Paul Walker
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Paul Walker
Date:01/16/2026
Rick Yang
Signature:/s/ Zachary Bambach
Name/Title:Zachary Bambach as attorney-in-fact for Rick Yang
Date:01/16/2026
Comments accompanying signature:
This Amendment No. 3 to Schedule 13D was executed by Zachary Bambach on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which is attached as Exhibit 3.

FAQ

How many Celcuity (CELC) shares do the NEA reporting persons beneficially own?

The reporting persons collectively report beneficial ownership of 2,910,561 shares of Celcuity Inc. common stock, as shown on Line 11 and Line 13 of each cover page.

What percentage of Celcuity (CELC) common stock do the NEA entities report owning?

Each reporting person lists beneficial ownership of 6.3% of Celcuity’s common stock, calculated using 46,271,259 shares outstanding as of November 6, 2025, as reported in Celcuity’s Form 10-Q filed on November 13, 2025.

What recent share distributions involving Celcuity (CELC) are disclosed in this Schedule 13D/A?

On January 14, 2026, GEO distributed 625,000 shares of Celcuity common stock to NEA 18 VGE, which then made a pro rata distribution to its partners for no consideration. NEA Partners 18 VGE received 9,375 shares and subsequently distributed them, including 7,577 shares to an entity associated with certain managers.

Were any Celcuity (CELC) shares sold by entities associated with the NEA managers?

The filing states that shares indirectly received by Anthony A. Florence, Jr., Mohamad H. Makhzoumi and Scott D. Sandell in the NEA Partners 18 VGE distribution were sold on January 15, 2026 as set forth on Schedule A.

What warrant exercises related to Celcuity (CELC) are described in this amendment?

On October 6, 2025, GEO elected to exercise 139,130 warrants for 1,391,300 GEO preferred warrant shares, which were immediately converted into 1,391,300 shares of Celcuity common stock. As of January 16, 2026, GEO no longer holds any warrants or preferred warrant shares.

What is the purpose of the NEA entities’ investment in Celcuity (CELC) according to the filing?

The filing states that GEO agreed to acquire the Celcuity shares for investment purposes. It notes that, depending on market conditions and other factors, GEO and the other reporting persons may dispose of or acquire additional shares, and it lists that they currently have no specific plans for corporate transactions or changes in control at Celcuity.

Who are the reporting persons in this Celcuity (CELC) Schedule 13D/A Amendment No. 3?

The reporting persons are Growth Equity Opportunities 18 VGE, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, and individual managers Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker and Rick Yang.

Celcuity Inc

NASDAQ:CELC

CELC Rankings

CELC Latest News

CELC Latest SEC Filings

CELC Stock Data

4.87B
38.03M
12.04%
84.06%
13.25%
Biotechnology
Services-medical Laboratories
Link
United States
MINNEAPOLIS